Fully human monoclonal antibodies against Ebola virus possess complete protection in a hamster model
Ebola disease is a lethal viral hemorrhagic fever caused by ebolaviruses within the Filoviridae family with mortality rates of up to 90%. Monoclonal antibody (mAb) based therapies have shown great potential for the treatment of EVD. However, the potential emerging ebolavirus isolates and the negativ...
Saved in:
Main Authors: | Wujian Li, Wanying Yang, Xueqin Liu, Wujie Zhou, Shen Wang, Zhenshan Wang, Yongkun Zhao, Na Feng, Tiecheng Wang, Meng Wu, Liangpeng Ge, Xianzhu Xia, Feihu Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2024.2392651 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ophthalmic Sequelae of Ebola Virus Disease in Survivors, Sierra Leone
by: Charlene H. Choo, et al.
Published: (2024-12-01) -
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial
by: Simon Valayer, et al.
Published: (2025-12-01) -
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches)
by: Conall H. Watson, et al.
Published: (2024-11-01) -
Menace of Ebola Virus Disease: A Review
by: Galadima, M.A., et al.
Published: (2021-12-01) -
Factores pronósticos clínicos determinantes en la supervivencia de pacientes con el virus Ébola
by: Osvaldo Miranda Gómez, et al.
Published: (2020-10-01)